87 related articles for article (PubMed ID: 24041228)
1. Intracellular expression of inflammatory proteins S100A8 and S100A9 leads to epithelial-mesenchymal transition and attenuated aggressivity of breast cancer cells.
Cormier K; Harquail J; Ouellette RJ; Tessier PA; Guerrette R; Robichaud GA
Anticancer Agents Med Chem; 2014 Jan; 14(1):35-45. PubMed ID: 24041228
[TBL] [Abstract][Full Text] [Related]
2. CRISPR-Cas9 based knockout of S100A8 in mammary epithelial cells enhances cell proliferation and triggers oncogenic transformation via the PI3K-Akt pathway: Insights from a deep proteomic analysis.
Singh P; Ali SA; Kumar S; Mohanty AK
J Proteomics; 2023 Sep; 288():104981. PubMed ID: 37544501
[TBL] [Abstract][Full Text] [Related]
3. RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial-mesenchymal transition.
Yin C; Li H; Zhang B; Liu Y; Lu G; Lu S; Sun L; Qi Y; Li X; Chen W
Breast Cancer Res Treat; 2013 Nov; 142(2):297-309. PubMed ID: 24177755
[TBL] [Abstract][Full Text] [Related]
4. S100A8/A9 promotes parenchymal damage and renal fibrosis in obstructive nephropathy.
Tammaro A; Florquin S; Brok M; Claessen N; Butter LM; Teske GJD; de Boer OJ; Vogl T; Leemans JC; Dessing MC
Clin Exp Immunol; 2018 Sep; 193(3):361-375. PubMed ID: 29746703
[TBL] [Abstract][Full Text] [Related]
5. Pax-5 is a potent regulator of E-cadherin and breast cancer malignant processes.
Benzina S; Beauregard AP; Guerrette R; Jean S; Faye MD; Laflamme M; Maïcas E; Crapoulet N; Ouellette RJ; Robichaud GA
Oncotarget; 2017 Feb; 8(7):12052-12066. PubMed ID: 28076843
[TBL] [Abstract][Full Text] [Related]
6. S100A8 and S100A9 are associated with endometrial shedding during menstruation.
Arai K; Kubota A; Iwasaki T; Sonoda A; Sakane J
Med Mol Morphol; 2023 Sep; 56(3):194-205. PubMed ID: 37085626
[TBL] [Abstract][Full Text] [Related]
7. Formation of Calprotectin Inhibits Amyloid Aggregation of S100A8 and S100A9 Proteins.
Baronaitė I; Šulskis D; Kopu Stas A; Tutkus M; Smirnovas V
ACS Chem Neurosci; 2024 May; 15(9):1915-1925. PubMed ID: 38634811
[TBL] [Abstract][Full Text] [Related]
8. Viaminate Inhibits
Cao J; Xu M; Zhu L; Xiao S
Curr Drug Targets; 2023; 24(13):1055-1065. PubMed ID: 37861037
[TBL] [Abstract][Full Text] [Related]
9. [Expression of S100A8 and A100A9 in giant cell tumor of bone and its relation with CT and MR imaging findings].
Liao JS; Ding XY; Xu SL
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2015 May; 44(3):329-34. PubMed ID: 26350015
[TBL] [Abstract][Full Text] [Related]
10. Robust shifts in S100a9 expression with aging: a novel mechanism for chronic inflammation.
Swindell WR; Johnston A; Xing X; Little A; Robichaud P; Voorhees JJ; Fisher G; Gudjonsson JE
Sci Rep; 2013; 3():1215. PubMed ID: 23386971
[TBL] [Abstract][Full Text] [Related]
11. Semaglutide ameliorates obesity-induced cardiac inflammation and oxidative stress mediated via reduction of neutrophil Cxcl2, S100a8, and S100a9 expression.
Pan X; Yang L; Wang S; Liu Y; Yue L; Chen S
Mol Cell Biochem; 2024 May; 479(5):1133-1147. PubMed ID: 37318712
[TBL] [Abstract][Full Text] [Related]
12. Influence of energy balance on the antimicrobial peptides S100A8 and S100A9 in the endometrium of the post-partum dairy cow.
Swangchan-Uthai T; Chen Q; Kirton SE; Fenwick MA; Cheng Z; Patton J; Fouladi-Nashta AA; Wathes DC
Reproduction; 2013 May; 145(5):527-39. PubMed ID: 23533291
[TBL] [Abstract][Full Text] [Related]
13. S100A8-Mediated Inflammatory Signaling Drives Colorectal Cancer Progression via the CXCL5/CXCR2 Axis.
Chen L; Shu P; Zhang X; Ye S; Tian L; Shen S; Ma J; Ai F; Li X
J Cancer; 2024; 15(11):3452-3465. PubMed ID: 38817853
[No Abstract] [Full Text] [Related]
14. Vildagliptin and its metabolite M20.7 induce the expression of S100A8 and S100A9 in human hepatoma HepG2 and leukemia HL-60 cells.
Asakura M; Karaki F; Fujii H; Atsuda K; Itoh T; Fujiwara R
Sci Rep; 2016 Oct; 6():35633. PubMed ID: 27759084
[TBL] [Abstract][Full Text] [Related]
15. Evolution of multifunctionality through a pleiotropic substitution in the innate immune protein S100A9.
Harman JL; Loes AN; Warren GD; Heaphy MC; Lampi KJ; Harms MJ
Elife; 2020 Apr; 9():. PubMed ID: 32255429
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of peripheral blood S100A12, S100A8, and S100A9 concentrations in idiopathic pulmonary fibrosis.
Ding D; Luan R; Xue Q; Yang J
Cytokine; 2023 Dec; 172():156387. PubMed ID: 37826869
[TBL] [Abstract][Full Text] [Related]
17. S100A8 and S100A9 in Hematologic Malignancies: From Development to Therapy.
Razmkhah F; Kim S; Lim S; Dania AJ; Choi J
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686186
[TBL] [Abstract][Full Text] [Related]
18. Generation and Application of Monoclonal Antibodies against Porcine S100A8, S100A9, and S100A12 Proteins Using Hybridoma Technology.
Xia P; Ma X; Yan L; Lian S; Li X; Luo Y; Chen Z; Ji X
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256103
[TBL] [Abstract][Full Text] [Related]
19. S100A8/S100A9 Promote Progression of Multiple Myeloma via Expansion of Megakaryocytes.
Lin C; Garcia-Gerique L; Bonner EE; Mastio J; Rosenwasser M; Cruz Z; Lawler M; Bernabei L; Muthumani K; Liu Q; Poncz M; Vogl T; Törngren M; Eriksson H; Vogl DT; Gabrilovich DI; Nefedova Y
Cancer Res Commun; 2023 Mar; 3(3):420-430. PubMed ID: 36923707
[TBL] [Abstract][Full Text] [Related]
20. Characterizing the Macrophage Population in Patients With Idiopathic Subglottic Stenosis.
Ospino R; Berges A; Mafla L; Collins S; Li YC; Lina I; Gelbard A; Hillel AT; Motz K
Laryngoscope; 2023 Sep; 133(9):2308-2316. PubMed ID: 36524603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
